title: [Dermatomyositis].
authors.affiliation: Service de médecine interne, hôpital Jean-Verdier, AP-HP, Université Paris-13, 93140 Bondy, France. olivier.fain@jvr.aphp.fr
authors.forename: Sylvain
authors.initials: S
authors.lastname: Glitho
authors.forename: Latifatou
authors.initials: L
authors.lastname: Boukari
authors.forename: Arsène
authors.initials: A
authors.lastname: Mekinian
authors.forename: Olivier
authors.initials: O
authors.lastname: Fain
mesh_terms: D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications / Q000175:diagnosis; D015283:Citalopram / Q000008:administration & dosage / Q000009:adverse effects*; D003863:Depression / Q000150:complications / Q000188:drug therapy*; D003882:Dermatomyositis / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D017035:Pravastatin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000960:Hypolipidemic Agents; D015283:Citalopram; D017035:Pravastatin